Statistical Papers

, Volume 60, Issue 2, pp 5–21 | Cite as

Adaptive designs for drug combination informed by longitudinal model for the response

  • Tobias MielkeEmail author
  • Vladimir Dragalin
Regular Article


Objectives in Phase II drug combination studies are to estimate the efficacy response surface for the combination of doses of different drugs and to select the most efficient combination for the final Phase III clinical trial. One problem is to find an optimal design that allocates subjects to the dose-combinations which will maximize the information obtained in the trial. Adaptive designs help in these situations to ensure high efficiency of the study design. We are using a binary efficacy endpoint and consider the practical situation when the timing of the endpoint assessment period on the subject level is considerably longer relative to the inter-arrival time of subjects. This poses implementation challenges for the adaptive design. A solution to the adaptive design problem by using time-to-event models as longitudinal model will be presented.


Adaptive design Dose combination study Delayed response 



  1. Atkinson AC, Donev AN, Tobias RD (2007) Optimum Experimental Designs, with SAS. Oxoford University Press, OxfordzbMATHGoogle Scholar
  2. Atkinson AC, Fedorov VV, Herzberg AM, Zhang R (2014) Elemental information matrices and optimal experimental design for generalized regression models. J Stat Plan Inference 144:81–91MathSciNetCrossRefzbMATHGoogle Scholar
  3. Cai C, Liu S, Yuan Y (2014) A Bayesian design for phase II clinical trials with delayed responses based on multiple imputation. Stat Med 33:4017–4028MathSciNetCrossRefGoogle Scholar
  4. Fedorov VV, Leonov SL (2013) Optimal Design for Nonlinear Response Models. Chapman & Hall/CRC Biostatistics Series, Boca RatonCrossRefzbMATHGoogle Scholar
  5. Finney D (1971) Probit Analysis. Cambridge University Press, CambridgezbMATHGoogle Scholar
  6. Kiefer J, Wolfowitz J (1960) The equivalence of two extremum problems. Can J Math 12:363–366MathSciNetCrossRefzbMATHGoogle Scholar
  7. Lehmann EL, Casella G (1998) Theory of Point Estimation, 2nd edn. Springer, New YorkzbMATHGoogle Scholar
  8. Liu S, Ning J (2013) A Bayesian dose-finding design for drug combination trials with delayed toxicities. Bayesian Anal 8:703–722MathSciNetCrossRefzbMATHGoogle Scholar
  9. Pronzato L, Pazman A (2013) Design of Experiments in Nonlinear Models. Springer, New YorkCrossRefzbMATHGoogle Scholar
  10. Wu CFJ (1988) Optimal design for percentile estimation of a quantal response curve. In: Dodge Y, Fedorov VV, Wynn HP (eds) Optimal Design and Analysis of Experiments. Elsevier, North Holland, pp 213–223Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.JanssenNeussGermany
  2. 2.JanssenSpring HouseUSA

Personalised recommendations